Company Filing History:
Years Active: 2016-2017
Title: Innovations of Dongting Zhangsun in Biochemistry
Introduction
Dongting Zhangsun is a prominent inventor based in Haikou, China. He has made significant contributions to the fields of biochemistry and molecular biology. With a total of two patents to his name, his work focuses on the development of conotoxin peptides and their pharmaceutical applications.
Latest Patents
Dongting Zhangsun's latest patents include the development of the αO-superfamily conotoxin peptide and a novel α-conotoxin peptide. The αO-superfamily conotoxin peptide is designed to block acetylcholine receptors and NMDA receptors, showing promise in treating conditions such as neuralgia, addiction, and various cancers. The α-conotoxin peptide also targets acetylcholine receptors and has potential applications in treating mental diseases and cancers, as well as aiding in analgesia and smoking cessation.
Career Highlights
Dongting Zhangsun is affiliated with Hainan University, where he conducts his research and development work. His innovative approaches in the pharmaceutical field have garnered attention for their potential therapeutic benefits.
Collaborations
Some of his notable coworkers include Sulan Luo and Yong Wu, who contribute to his research endeavors.
Conclusion
Dongting Zhangsun's work in biochemistry and molecular biology highlights the importance of innovation in developing new therapeutic agents. His patents reflect a commitment to advancing medical science and improving patient outcomes.